NEW YORK, July 30, 2022 /PRNewswire/ —
WHY: The Rosen Law Firm, a global investor rights law firm, reminds buyers of the values of Verrica Pharmaceuticals Inc. VRCA Among May 28, 2021 Y May 24, 2022both dates inclusive (the “Class Period”), of the important August 5, 2022 Deadline for Lead Plaintiff.
AND THAT: If you purchased Verrica securities during the Class Period, you may be entitled to compensation without paying any fees or out-of-pocket costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Verrica class action lawsuit, go to https://rosenlegal.com/send-form/?case_id=6828 or call Philip Kim, Esq. toll free at 866-767-3653 or email [email protected] either [email protected] for information about the class action lawsuit. A class action lawsuit has already been filed. If you want to serve as lead plaintiff, you must transfer to the Court no later than August 5, 2022. A lead plaintiff is a representative party acting on behalf of other class members to direct the litigation.
WHY ROSEN’S LAW: We encourage investors to select qualified advisors with a track record of success in leadership roles. Often the companies that issue ads do not have comparable experience, resources, or any significant recognition from their peers. Many of these firms do not actually handle securities class action lawsuits, but are simply intermediaries who refer clients or partner with law firms that actually litigate the cases. Be wise in selecting an attorney. The Rosen Law Firm represents investors around the world, concentrating its practice on securities class action and shareholder derivative litigation. The Rosen Law Firm has achieved the largest securities class action settlement in history against a Chinese company. The Rosen Law Firm was ranked #1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017. The firm has been ranked in the top 4 every year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone, the company secured more than $438 million for investors In 2020, founding partner Laurence Rosen was named by law360 as a Titan of the Plaintiffs Bar Association. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
CASE DETAILS: According to the lawsuit, the defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) there were manufacturing deficiencies at the facility where Verrica’s contract manufacturer produced a bulk solution for VP-102 (a combination drug device of Verrica’s topical solution, cantharidin, delivered via a single-use precision applicator for the treatment of molluscum contagiosum); (2) these deficiencies were not remedied when Verrica resubmitted his New Drug Application (“NDA”) to the US Food and Drug Administration (“FDA”) for VP-102 for molluscs; (3) the foregoing presented significant risks for Verrica to obtain regulatory approval of VP-102 for shellfish; and (4) as a result of the foregoing, Defendants’ positive statements about Verrica’s business, operations, and prospects were materially misleading and/or lacked reasonable basis. When the true details entered the market, the suit claims that investors suffered damages.
To join the Verrica class action lawsuit, go to https://rosenlegal.com/send-form/?case_id=6828 or call Philip Kim, Esq. toll free at 866-767-3653 or email [email protected] either [email protected] for information about the class action lawsuit.
No class has been certified. Until a class is certified, you are not represented by an attorney unless you retain one. You can select the attorney of your choice. You can also remain a member of the absent class and do nothing at this time. An investor’s ability to participate in any potential future recovery is not dependent on him acting as the lead claimant.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firmin Twitter: https://twitter.com/rosen_firm or in Facebook: https://www.facebook.com/rosenlawfirm/.
Lawyer advertising. Previous results do not guarantee a similar result.
Contact information:
Laurence Rosen, Esq.
Philip Kim, Esq.
The Rosen Law Firm, Pennsylvania
275 Madison Avenue, 40th Floor
New York, NY 10016
Phone: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.es
View original content to download media:https://www.prnewswire.com/news-releases/vrca-investor-notice-rosen-globally-respected-investor-counsel-encourages-verrica-pharmaceuticals-inc-investors-with-losses-to-secure-counsel- before-the-date-important-date-of-august-5-in-securities-class-action–vrca-301596500.html
SOURCE Rosen Law Firm, Pennsylvania